Studies Show New Weight Loss Medications are the Real Deal, plus some data on what happens when we stop taking them

Back in 2021 we did an episode on Semaglutide, the then-recently-approved drug for weight loss that was originally approved for Type 2 diabetes. Since that episode another paper has come out on what happens to weight when the drug is discontinued, and another on Mounjaro, a drug approved for Type 2 diabetes. Let’s take a look.